◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Marvel Biosciences Corp. — SEDAR+ Filings

Open SEDAR+
All Annual Reports 7 Quarterly Reports 16 MD&A 23 News Releases 59 Material Changes 6 Prospectuses 2 Governance 8 Certifications 48 Other 49
DocumentTypeFiling DatePeriodStatus
Notice of meeting - English.pdf Other 2026-01-20 -- PDF
Other.pdf Other 2026-01-20 -- PDF
Notice of the meeting and record date - English.pdf Other 2025-12-04 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Other 2025-11-28 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Other 2025-11-28 -- PDF
Letter from former auditor.pdf Other 2025-09-18 -- PDF
Notice.pdf Other 2025-09-18 -- PDF
Letter from successor auditor.pdf Other 2025-09-18 -- PDF
Report of exempt distribution (45-106F1).pdf Other 2025-05-16 -- PDF
Report of exempt distribution (45-106F1).pdf Other 2025-04-17 -- PDF
Notice of the meeting and record date - English.pdf Other 2024-12-20 -- PDF
Notice of the meeting and record date (amended) - English.pdf Other 2024-12-18 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Other 2024-11-28 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Other 2024-11-28 -- PDF
Notice of the meeting and record date - English.pdf Other 2024-11-21 -- PDF
Report of exempt distribution (45-106F1).pdf Other 2024-07-29 -- PDF
Notice of meeting - English.pdf Other 2023-12-14 -- PDF
Notice of meeting - English.pdf Other 2023-12-08 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Other 2023-11-28 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Other 2023-11-28 -- PDF
Notice of the meeting and record date - English.pdf Other 2023-10-26 -- PDF
Notice of the meeting and record date - English.pdf Other 2022-12-22 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2022-11-23 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2022-11-23 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2022-08-17 -- PDF
Notice of the meeting and record date - English.pdf Other 2021-12-13 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2021-11-16 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2021-11-16 -- PDF
Financial statements of RTO acquirer.pdf Other 2021-09-23 -- PDF
Financial statements of RTO acquirer.pdf Other 2021-09-23 -- PDF
Notice.pdf Other 2021-09-21 -- PDF
Other securityholders documents - English.pdf Other 2021-08-30 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2021-06-18 -- PDF
Other.pdf Other 2020-12-18 -- PDF
Other.pdf Other 2020-12-01 -- PDF
Other.pdf Other 2020-11-18 -- PDF
Notice of meeting - English.pdf Other 2020-11-18 -- PDF
Other.pdf Other 2020-11-03 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2020-10-16 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2020-10-16 -- PDF
Notice of the meeting and record date - English.pdf Other 2020-10-16 -- PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2019-11-07 -- PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Other 2019-11-07 -- PDF
Decision Document (Final).pdf Other 2019-01-30 -- PDF
Escrow agreement.pdf Other 2019-01-30 -- PDF
Other.pdf Other 2019-01-30 -- PDF
Auditors' consent letter.pdf Other 2019-01-30 -- PDF
Consent letter(s) of other expert(s).pdf Other 2019-01-25 -- PDF
Decision Document (Preliminary).pdf Other 2018-12-24 -- PDF
NEWS
Loading news...
TRENDING
Loading...